GlaxoSmithKline: all 4,196 studies
Page 36 of 42. Open to participants first (141), then studies with results posted, then the rest; newest registration first within each.
- Comparison of the Efficacy and Tolerability of the Addition of AVANDIA to Submaximal Doses of MetforminCompletedNCT00501020Phase 4
- Rosiglitazone on Microalbuminuria in Type 2 DiabeticsCompletedNCT00500955Phase 3
- Study To Examine Safety, Tolerability And Pharmacokinetics Of Intravenous Doses And Oral Dose Of GSK233705CompletedNCT00500461Phase 1
- A Healthy Volunteer Study to Assess the Relative Bioavailability of 2 Forms of SB773812 Tablets.CompletedNCT00500201Phase 1
- A Phase I, Dose-Escalation Study to Assess the Safety and Biological Activity of Recombinant Human Interleukin-18CompletedNCT00500058Phase 1
- A Study To Investigate The Metabolism And Excretion Of 14C SB-751689 Given To Healthy Males And Postmenopausal WomenCompletedNCT00499928Phase 1
- Efficacy and Safety Study of Rosiglitazone/Metformin Therapy vs Rosiglitazone and Metformin in Type 2 Diabetes SubjectsCompletedNCT00499707Phase 3
- 15-Day Repeated-Dose Study With SB-649868 And Its Interaction With CYP3A4 Isoenzyme In Healthy Male Subjects.CompletedNCT00495729Phase 1
- Bioequivalence and Food Effect Study in Healthy VolunteersCompletedNCT00495274Phase 1
- Study To Investigate The Safety And Metabolism Of GSK376501 In Overweight SubjectsCompletedNCT00495014Phase 1
- Investigation Of Weight Loss And Body Composition Changes After Dosing With Either Placebo Or One Of Two Active DrugsCompletedNCT00494767Phase 1
- Open-label Study to Investigate the Safety, Tolerability, PK, and Pharmacodynamics of the AKT Inhibitor GSK690693TerminatedNCT00493818Phase 1
- Cetirizine Placebo Controlled Study For Perennial Allergic RhinitisCompletedNCT00490204Phase 3
- Hospital-based Surveillance to Collect Prospective Data to Estimate the Disease Burden of Severe RV GE in SwedenCompletedNCT00489567
- Study Of Pharmacokinetics and Pharmacodynamics Effects Of GSK256073A On Healthy VolunteersCompletedNCT00488449Phase 1
- GSK372475 Bioequivalence StudyCompletedNCT00488098Phase 1
- Eltrombopag Taste Testing in Healthy Adult VolunteersCompletedNCT00487968Phase 1
- Examine the Effect of Repeat Inhaled Doses of GW870086X on Lung Function in Mild Asthmatic Male SubjectsCompletedNCT00483899Phase 1
- A Phase I Topotecan Study in Subjects With Cancer and Impaired Renal FunctionCompletedNCT00483860Phase 1
- Oral Contraceptive Interaction Study for GW273225TerminatedNCT00483535Phase 1
- Prospective Epidemiological Study Of The Prevalence Of HLA-B*5701 In HIV-1 Infected PatientsCompletedNCT00481390
- Co-Administration Of Fosamprenavir With Methadone: A Drug Interaction Study.CompletedNCT00481182Phase 1
- Successful Control and Clinical Effectiveness Of SERETIDE(Salmeterol/Fluticasone Propionate) Study In Asthma.(SUCCESS)CompletedNCT00480649Phase 4
- CONCEPT: A 1-Year Comparison Of A Stable Dose Of SERETIDE® Inhaler With An Adjustable Maintenance Dose Of SYMBICORT® Inhaler. SERETIDE® Inhaler is a Trademark of GSK Group of Companies. SYMBICORT® Inhaler is a Trademark of Astra Zeneca.CompletedNCT00479739Phase 4
- A Study Of The Effects Of CB2 Compound Of GW842166 In Patients With OsteoarthritisCompletedNCT00479427Phase 2
- A 2 Part Study Examining Doses Of GSK961081 In Healthy Volunteers And Then In COPD PatientsCompletedNCT00478738Phase 2
- Part A: Radiolabel Study With GW786034 Part B: Single Dose of GW786034CompletedNCT00478725Phase 1
- Human Papillomavirus Vaccine Safety & Immunogenicity Trial in Healthy Young Adult Women With HPV Vaccine (GSK1674330A)CompletedNCT00478621Phase 1
- Immunogenicity and Reactogenicity of Fluarix™ (Influsplit SSW®) 2007/2008 in People 18 Years Old or AboveCompletedNCT00476307Phase 3
- A Single Centre Randomized Study Evaluating The Safety And Tolerability Of GSK573719 In Healthy VolunteersCompletedNCT00475436Phase 1
- Study To Evaluate The Effects Of GW856553 On Endothelial Function/Vascular Compliance In Subjects With Dyslipidaemia.CompletedNCT00474864Phase 2
- An Imaging Study to Investigate the Distribution of GSK239512 in the Brain.CompletedNCT00474513Phase 1
- Characterize The Modulatory Effects Of Dopamine D2/D3 Receptor Agonist And Antagonist Drugs On Compulsive BehaviorsCompletedNCT00471588Phase 1
- A Study To Compare Emotional Changes In Subjects With Social Anxiety DisorderCompletedNCT00470483Phase 1
- Comparison Of Two Tablet Formulations Of SB-568859CompletedNCT00470145Phase 1
- Study Of White Blood Cells In The Cerebrospinal Fluid And Blood Of Patients With Relapsing Forms Of Multiple SclerosisCompletedNCT00469378Phase 2
- Safety, Blood Levels and Effects of GW642444CompletedNCT00469040Phase 1
- A Study To Demonstrate The Bioequivalence Of Rosiglitazone XR (BRL-049653) 8mgs XR Manufactured At Two Different Sites.CompletedNCT00468897Phase 1
- Study of Safety, Blood Levels and Brain Receptor Occupancy of GSK598809 Using PET Imaging in Health Males.CompletedNCT00468806Phase 1
- Evaluation Of SB-751689 Administered At Supratherapeutic Dose Levels In Healthy Adult Subjects.CompletedNCT00468689Phase 1
- A Study To Investigate The Effect Of Inhaling A Single Dose Of GW642444M In Asthmatic PatientsCompletedNCT00463697Phase 1
- A Study To Evaluate The Safety, Tolerability And Pk Of Pazopanib Eye Drops In Healthy Adult And Elderly Subjects.CompletedNCT00463320Phase 1
- GW572016 In Patients With Advanced Or Metastatic Breast CancerCompletedNCT00462956Phase 1
- A Study to Assess the Safety and Interaction Between Casopitant and Ketoconazole When Taken By Healthy AdultsCompletedNCT00460707Phase 1
- Lamictal Bipolar Observational StudyCompletedNCT00460226
- Parkinson's Disease Patient Study On Absorption, Distribution, Metabolism And Excretion Of RopiniroleCompletedNCT00460148Phase 2
- Clinical Study Of Migraine EvolutionCompletedNCT00460005
- A Clinical Study to Assess Single and Repeat Doses of a New Medication (GSK933776) in Patients With Alzheimer's DiseaseCompletedNCT00459550Phase 1
- Absorption, Distribution, Metabolism And Excretion Study For GSK221149ACompletedNCT00457925Phase 1
- GI-270384 Study In Patients With Mild To Moderate Ulcerative ColitisTerminatedNCT00457171Phase 1
- No Resistance After Long Term Treatment SERETIDEWithdrawnNCT00456313Phase 4
- Cancer Immunotherapy GSK1572932A as Adjuvant Therapy for Patients With Tumor-antigen-positive Non-Small Cell Lung CancerTerminatedNCT00455572Phase 1
- The Safety and Tolerability of GW805858 in Healthy Volunteers and Mild AsthmaticsTerminatedNCT00453791Phase 1
- A Study To Investigate The Effect Of Inhaled Fluticasone Propionate On The Bronchial Responsiveness To Leukotriene D4 In Asthmatics PatientsCompletedNCT00453778Phase 4
- A Single Centre Randomized Study Evaluating The Safety And Tolerability Of GSK233705 In Healthy Volunteers.CompletedNCT00453687Phase 1
- Prospective Epidemiological Study Of The Prevalence Of HLA-B*5701CompletedNCT00453440
- Study to Assess Safety & Immunogenicity of GSK Biologicals' Boostrix (dTpa) Vaccine vs. Chinese DT VaccineCompletedNCT00452686Phase 3
- Bioequivalence And Effect Of Food And Water On Lamotrigine in Healthy VolunteersCompletedNCT00449774Phase 1
- A Study To Assess The Pharmacokinetics Of Different Modified Release Formulations Of GSK221149 In Healthy Adult SubjectsTerminatedNCT00449709Phase 1
- Study To Evaluate Long Term Maintenance With TRIZIVIR After Boosted Protease Inhibitor (PI) Or Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) In HIV-1 Infected AdultsCompletedNCT00449436Phase 4
- Evaluation of Single and Repeat Doses of GSK729327 in Healthy VolunteersCompletedNCT00448890Phase 1
- A Study Of New Medicine (GSK 372475) For The Treatment Of DepressionCompletedNCT00448058Phase 2
- A Study of GW842166 in Adults With Osteoarthritis PainCompletedNCT00447486Phase 2
- This Study Will Examine the Effects of GSK256066 to Protect Mild Steroid-naive Asthmatics Against an Antigen ChallengeCompletedNCT00445510Phase 2
- Dental Pain 3rd Molar Tooth Extraction GW842166CompletedNCT00444769Phase 2
- Single Dose GW685698X Magnesium Stearate Study In Asthmatic Patients.CompletedNCT00444509Phase 1
- A Placebo-controlled Study to Investigate the Safety, and Pharmacokinetics of Oral GSK626616AC in Healthy SubjectsCompletedNCT00443170Phase 1
- Characterisation of the Immune Responses of 2 Experimental Malaria VaccinesCompletedNCT00443131Phase 2
- Study Of SB-497115 in Healthy Subjects and Subjects With Mild, Moderate or Severe Renal ImpairmentCompletedNCT00442871Phase 1
- Prospective Epidemiological Study Of The Prevalence Of HLAB*5701 In HIV-1 Infected PatientsCompletedNCT00441688Phase 4
- A Long Term Prospective Follow Up Study For The CATO Study (SAS30018/SER9702)CompletedNCT00441675
- Disturbed Sleep Model Study.CompletedNCT00440323Phase 1
- The Effects Of GW679769 (Casopitant) On The Pharmacokinetics Of Docetaxel In Subjects With CancerCompletedNCT00440128Phase 1
- Monotherapy Versus Placebo Over 14 or 17 Days in Healthy and Hepatitis C Infected AdultsTerminatedNCT00439959Phase 1
- A Study To Look At The Safety Of SB-681323 In Healthy Adult Subjects After Intravenous Administration Of A Single DoseCompletedNCT00439881Phase 1
- A Study To Evaluate The Effect Of WELLBUTRIN XL On Intraocular PressureCompletedNCT00439868Phase 1
- A Study To Investigate The Safety, Tolerability And Blood Levels Of GSK598809CompletedNCT00437840Phase 1
- Study To Investigate If Repeat Doses Of GSK598809 Are Safe And Well Tolerated And To Evaluate Blood Levels Of GSK598809CompletedNCT00437632Phase 1
- Odiparcil QT Definitive StudyTerminatedNCT00437242Phase 1
- A Study to Assess the Safety & Interaction Between GW679769, Dexamethasone, & Ondansetron When Taken by Healthy AdultsCompletedNCT00437229Phase 1
- A Study To Assess GW677954 Used In Combination With Insulin In Subjects Who Have Type 2 Diabetes MellitusTerminatedNCT00437164Phase 2
- Implementing Hospital-based Active Surveillance Procedures for Vaccine Safety Monitoring at IMSS Hospitals in MexicoCompletedNCT00436358
- To Study And Compare Bioavailability And Safety Of Four Different Formulations Of The Study DrugCompletedNCT00436228
- A Study of Patient Management in HIV-1 Infected Patients Found to Have the Genetic Marker HLA-B*5701CompletedNCT00435838
- Study Of Safety, Blood Levels, And Brain Receptor Occupancy Of GSK163090 Using PET Imaging In Healthy MalesCompletedNCT00435695Phase 1
- Study to Evaluate Safety and Immunogenicity of the GSK Bio CMV Vaccine in CMV-seronegative Healthy Male Adult SubjectsCompletedNCT00435396Phase 1
- A Study of the Drug Casopitant for the Prevention of Nausea Caused By Cisplatin-Based Highly Emetogenic ChemotherapyCompletedNCT00431236Phase 3
- Trial With Allergic Rhinitis Patients Taking GSK256066 Versus Placebo In A Pollen Challenge ChamberCompletedNCT00430157Phase 2
- A Study To Investigate The Metabolism Of GW876008 In Smokers Compared To Non-Smokers.CompletedNCT00429728Phase 1
- Assess Efficacy, Immune Response & Safety of 2 Doses of Oral Live Attenuated HRV Vaccine at Different Viral Concentrations in Healthy InfantsCompletedNCT00429481Phase 2
- A Two-Part Study to Determine: Best Medication Formulation and Food EffectCompletedNCT00427596Phase 1
- A Three-Part Study Of GSK580416 In Healthy SubjectsCompletedNCT00427141Phase 1
- To Evaluate The Effects Of SB-649868 (10, 30 Mg And 60 Mg) On Subjects With Primary InsomniaCompletedNCT00426816Phase 2
- To Investigate Effects GSK561679 on Part of the Body's System That Controls the Balance of Many of the Hormones.CompletedNCT00426608Phase 1
- Assess Efficacy, Immune Response & Safety of 2 Doses of Oral Live Attenuated HRV Vaccine in Healthy InfantsCompletedNCT00425737Phase 2
- A Study to Investigate the Effects of GW876008 on Brain Activation During Emotional Processing in Healthy Subjects.CompletedNCT00424697Phase 1
- A Study of GSK1325760A in Healthy Japanese SubjectsCompletedNCT00424034Phase 1
- An Investigation To Determine The Potential Interaction Effect Between GW876008 And Midazolam.CompletedNCT00423761Phase 1
- A Study To Investigate The Effects Of End Stage Renal Disease And Hemodialysis On The Pharmacokinetics Of RopiniroleCompletedNCT00422994Phase 1
- Fluid Retention in Rosiglitazone Treated Subjects With Autonomic Neuropathy.CompletedNCT00422955Phase 3